tiprankstipranks
Trending News
More News >

Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Cadrenal Therapeutics (CVKD) to $32 from $3 and keeps a Buy rating on the shares following the 1-for-15 reverse stock split.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue